DeepMed Research

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.nebraska.edu

Clinical Trials

Utility of Bedside Ultrasound in the Prediction of Difficult Airway

Completed

Conditions: Laryngoscopy

First Posted Date: 2008-11-27

Last Posted Date: 2023-08-30

Lead Sponsor: University of Nebraska

Target Recruit Count: 162

Registration Number: NCT00799357

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Emergency Department Interventions to Improve Blood Pressure Follow-up

Not Applicable

Completed

Conditions: Hypertension

Interventions: Behavioral: Risk counseling

First Posted Date: 2008-11-26

Last Posted Date: 2023-09-15

Lead Sponsor: University of Nebraska

Target Recruit Count: 10

Registration Number: NCT00798551

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Improving Function, Quality of Life, Glycemia in Diabetics With Dementia

Phase 4

Withdrawn

Conditions: Alzheimer's Disease
Apathy
Dementia
Diabetes Mellitus

Interventions: Drug: Methylphenidate
Drug: Placebo

First Posted Date: 2008-11-18

Last Posted Date: 2023-08-15

Lead Sponsor: University of Nebraska

Registration Number: NCT00792662

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States
🇺🇸
Veterans Affairs Medical Center, Omaha, Nebraska, United States

Effect of Exercise on the Disease Activity of Rheumatoid Arthritis

Not Applicable

Completed

Conditions: Rheumatoid Arthritis

Interventions: Other: Aerobic and resistance exercise training

First Posted Date: 2008-11-18

Last Posted Date: 2023-08-30

Lead Sponsor: University of Nebraska

Target Recruit Count: 55

Registration Number: NCT00792675

Locations: 🇺🇸
Physical Activity Lab, University of Nebraska Omaha, Omaha, Nebraska, United States

Effect of Panretinal Photocoagulation on Optic Nerve Head Topography

Terminated

Conditions: Diabetic Retinopathy

First Posted Date: 2008-10-07

Last Posted Date: 2023-08-23

Lead Sponsor: University of Nebraska

Target Recruit Count: 13

Registration Number: NCT00767884

Locations: 🇺🇸
UNMC Truhlsen Eye Institute, Omaha, Nebraska, United States
🇺🇸
University of Nebraska Medical Center Eye Clinic, Omaha, Nebraska, United States

Increasing Physical Activity of Patients With Head and Neck Cancer (I-PAP Study)

Not Applicable

Withdrawn

Conditions: Head and Neck Cancer

Interventions: Behavioral: Intervention group

First Posted Date: 2008-09-22

Last Posted Date: 2023-08-16

Lead Sponsor: University of Nebraska

Registration Number: NCT00756795

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Long Acting Stimulant Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Young Children

Phase 4

Completed

Conditions: Attention Deficit Hyperactivity Disorder

Interventions: Drug: methylphenidate

First Posted Date: 2008-09-17

Last Posted Date: 2023-10-05

Lead Sponsor: University of Nebraska

Target Recruit Count: 7

Registration Number: NCT00754208

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Vitamin D Replacement After Kidney Transplant

Not Applicable

Completed

Conditions: Vitamin D Deficiency
Kidney Transplantation

Interventions: Dietary Supplement: vitamin D3

First Posted Date: 2008-09-08

Last Posted Date: 2024-10-26

Lead Sponsor: University of Nebraska

Target Recruit Count: 116

Registration Number: NCT00748618

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients With Short Bowel Syndrome (SBS)

Phase 4

Terminated

Conditions: Short Bowel Syndrome

Interventions: Drug: Growth Hormone

First Posted Date: 2008-08-27

Last Posted Date: 2023-09-08

Lead Sponsor: University of Nebraska

Target Recruit Count: 5

Registration Number: NCT00742157

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma

Early Phase 1

Terminated

Conditions: Contiguous Stage II Adult Diffuse Large Cell Lymphoma
Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma
Stage I Adult Diffuse Large Cell Lymphoma
Stage III Adult Diffuse Large Cell Lymphoma
Stage IV Adult Diffuse Large Cell Lymphoma

Interventions: Biological: oblimersen sodium
Biological: rituximab
Drug: cyclophosphamide
Drug: doxorubicin hydrochloride
Drug: vincristine sulfate
Drug: prednisone
Procedure: biopsy
Genetic: microarray analysis
Other: immunohistochemistry staining method
Genetic: gene expression analysis
Genetic: cytogenetic analysis

First Posted Date: 2008-08-15

Last Posted Date: 2023-10-24

Lead Sponsor: University of Nebraska

Target Recruit Count: 37

Registration Number: NCT00736450

Locations: 🇺🇸
Saint Francis Medical Center, Grand Island, Nebraska, United States
🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy